Table 2.

Levels of fasting blood glucose (FBG) in the STZ-induced diabetic rats treated with adalimumab when compared with the controls

Groups	Fasting blood glucose (mmol/L) Mean (SEM)
Group 1 (n = 7)	6.91 (0.11)
Group2 (n = 7)	15.43 (0.44)
Group 3 (n = 7)	8.07 (0.17)
Group 4 (n = 7)	4.85 (0.35)
F statistic	330.567
P-value	< 0.001
Post-hoc using a pair-wise comparison
Group Comparison	P-values
Group 1 versus Group 2	< 0.001
Group 1 versus Group 3	0.004
Group 1 versus Group 4	< 0.001
Group 2 versus Group 3	< 0.001
Group 2 versus Group 4	< 0.001
Group 3 versus Group 4	< 0.001

Values are mean (SEM); n = number of subjects; group 1 = obese, diabetic, treated rats; group 2 = obese, diabetic, untreated rats; group 3 = obese, non-diabetic, control rats; group 4 = non-obese, non-diabetic, control rats